Alkermes plc. Files 8-K: Material Agreement & Financial Update
Ticker: ALKS · Form: 8-K · Filed: 2025-10-22T00:00:00.000Z
Sentiment: neutral
Topics: material-agreement, financial-obligation, regulation-fd
TL;DR
Alkermes dropped an 8-K on Oct 22nd - looks like a big deal and financial stuff is happening.
AI Summary
On October 22, 2025, Alkermes plc. filed an 8-K report detailing a material definitive agreement and results of operations. The filing also disclosed the creation of a direct financial obligation and included Regulation FD disclosures. Specific financial figures or details of the agreement were not immediately available in the provided text.
Why It Matters
This 8-K filing indicates significant corporate activity for Alkermes, potentially involving new financial commitments or operational changes that could impact its financial condition and future performance.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement and financial obligations, which inherently carry risks that need further investigation.
Key Players & Entities
- Alkermes plc. (company) — Registrant
- October 22, 2025 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Alkermes plc.?
The provided text of the 8-K filing does not specify the details of the material definitive agreement, only that it is a reportable item.
What are the specific results of operations and financial condition being reported by Alkermes plc.?
The filing indicates that results of operations and financial condition are being reported, but the specific details are not included in the provided excerpt.
What is the direct financial obligation created by Alkermes plc.?
The filing confirms the creation of a direct financial obligation, but the specific terms and amount are not detailed in the provided text.
What is the purpose of the Regulation FD Disclosure in this filing?
The filing includes a Regulation FD Disclosure, which is typically used to ensure that material information is broadly disseminated to the public, but the specific content of this disclosure is not provided.
When was Alkermes plc. previously known as Antler Science Two Ltd?
Alkermes plc. was formerly known as Antler Science Two Ltd, with a date of name change on May 9, 2011.
Filing Stats: 4,637 words · 19 min read · ~15 pages · Grade level 17 · Accepted 2025-10-22 09:09:18
Key Financial Figures
- $0.01 — on which registered Ordinary shares, $0.01 par value ALKS Nasdaq Global Select
- $18.50 — proposed offer, the "Acquisition"), for $18.50 per ordinary share, nominal value $0.01
- $1.50 — a potential additional cash payment of $1.50 per Avadel Share, contingent upon achie
- $1,231,459,813.22 — an aggregate principal amount of up to $1,231,459,813.22 that is available to finance the paymen
Filing Documents
- d946576d8k.htm (8-K) — 71KB
- d946576dex21.htm (EX-2.1) — 609KB
- d946576dex22.htm (EX-2.2) — 24KB
- d946576dex101.htm (EX-10.1) — 907KB
- d946576dex991.htm (EX-99.1) — 302KB
- d946576dex992.htm (EX-99.2) — 26KB
- g946576ex99_2s10g1.jpg (GRAPHIC) — 92KB
- g946576ex99_2s11g1.jpg (GRAPHIC) — 75KB
- g946576ex99_2s12g1.jpg (GRAPHIC) — 75KB
- g946576ex99_2s13g1.jpg (GRAPHIC) — 31KB
- g946576ex99_2s1g1.jpg (GRAPHIC) — 58KB
- g946576ex99_2s2g1.jpg (GRAPHIC) — 143KB
- g946576ex99_2s3g1.jpg (GRAPHIC) — 138KB
- g946576ex99_2s4g1.jpg (GRAPHIC) — 141KB
- g946576ex99_2s5g1.jpg (GRAPHIC) — 186KB
- g946576ex99_2s6g1.jpg (GRAPHIC) — 95KB
- g946576ex99_2s7g1.jpg (GRAPHIC) — 92KB
- g946576ex99_2s8g1.jpg (GRAPHIC) — 126KB
- g946576ex99_2s9g1.jpg (GRAPHIC) — 93KB
- g946576g77z01.jpg (GRAPHIC) — 12KB
- 0001193125-25-245852.txt ( ) — 4411KB
- alks-20251022.xsd (EX-101.SCH) — 3KB
- alks-20251022_lab.xml (EX-101.LAB) — 18KB
- alks-20251022_pre.xml (EX-101.PRE) — 11KB
- d946576d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits EXHIBIT INDEX Exhibit No. Description 2.1 Transaction Agreement, dated as of October 22, 2025 by and among Alkermes plc and Avadel Pharmaceuticals plc.* 2.2 Appendix III to the Rule 2.7 Announcement, dated as of October 22, 2025 (Conditions Appendix). 10.1 Bridge Credit Agreement, dated as of October 22, 2025 by and among Alkermes plc, Alkermes, Inc. and JPMorgan Chase Bank, N.A.* 99.1 Rule 2.7 Announcement, dated as of October 22, 2025. 99.2 Alkermes plc Investor presentation dated October 22, 2025. 104 Cover page interactive data file (embedded within the Inline XBRL document). * Certain schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request. Responsibility Statement Required by the Takeover Rules The members of Alkermes' board of directors accept responsibility for the information contained in this Current Report on Form 8-K other than that relating to Avadel, its Subsidiaries and Avadel's board of directors and members of their immediate families, related trusts and persons connected with them. To the best of the knowledge and belief of the members of Alkermes' board of directors (who have taken all reasonable care to ensure that such is the case), the information contained in this Current Report on Form 8-K for which they accept responsibility is in accordance with the facts and does not omit anything likely to affect the import of such information. No Offer or Solicitation This Current Report on Form 8-K is for information purposes only and is not intended to and does not constitute, or form part of, an offer, invitation or the solicitation of an offer or invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the transa